Clinical Trial Update: Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing efficacy and safety of Xalost S in glaucoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Xalost S

Snippet

Sponsor: Taejoon Pharmaceutical Co., Ltd. | Conditions: Glaucoma | Phase 4 | Status: UNKNOWN